Literature DB >> 27521359

Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro.

Anna B Kawiecki1, Rebecca C Christofferson1.   

Abstract

Zika virus has emerged in the Americas, where dengue virus is endemic. Among the 4 serotypes of dengue virus, antibody-dependent enhancement is thought to enhance viral replication and disease severity. Reports suggest that anti-dengue virus antibody may enhance Zika virus replication. We investigated whether Zika virus antibodies enhance dengue virus replication, by exposing C57Bl/6 mice to Zika virus. Polyclonal serum was verified for strong Zika virus-neutralizing, dengue virus-subneutralizing capacity. Then we determined the enhancement capabilities of Zika virus-immune serum for dengue virus in vitro. We showed that Zika virus antibodies have the ability to enhance dengue virus infections, which is important, because in many Zika virus-affected areas, dengue virus is expected to remain endemic.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Zika; antibody; antibody dependent enhancement; dengue; enhancement; plaque reduction neutralization test (PRNT)

Mesh:

Substances:

Year:  2016        PMID: 27521359     DOI: 10.1093/infdis/jiw377

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  63 in total

1.  A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid Protein Protects Mice from Viral Infection.

Authors:  Xiaodan Shi; Jingping Hu; Jing Guo; Chuanjian Wu; Sidong Xiong; Chunsheng Dong
Journal:  Virol Sin       Date:  2019-02-28       Impact factor: 4.327

2.  A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein.

Authors:  Panke Qu; Chao Zhang; Min Li; Weimin Ma; Pei Xiong; Qingwei Liu; Gang Zou; Dimitri Lavillette; Feifei Yin; Xia Jin; Zhong Huang
Journal:  Cell Discov       Date:  2020-02-04       Impact factor: 10.849

3.  Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.

Authors:  Angela M Fowler; William W Tang; Matthew P Young; Anila Mamidi; Karla M Viramontes; Melanie D McCauley; Aaron F Carlin; Robert T Schooley; Jesica Swanstrom; Ralph S Baric; Jennifer Govero; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2018-11-14       Impact factor: 21.023

Review 4.  Using Macaques to Address Critical Questions in Zika Virus Research.

Authors:  Dawn M Dudley; Matthew T Aliota; Emma L Mohr; Christina M Newman; Thaddeus G Golos; Thomas C Friedrich; David H O'Connor
Journal:  Annu Rev Virol       Date:  2019-06-10       Impact factor: 10.431

5.  Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.

Authors:  Thomas F Rogers; Eileen C Goodwin; Bryan Briney; Devin Sok; Nathan Beutler; Alexander Strubel; Rebecca Nedellec; Khoa Le; Michael E Brown; Dennis R Burton; Laura M Walker
Journal:  Sci Immunol       Date:  2017-08-18

6.  A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Jenny C Cardenas; Alex Hall; Omar G Perez; Lucio Cardenas; Adam Hartstone-Rose; Scott B Halstead; Tonya M Colpitts
Journal:  J Gen Virol       Date:  2017-07-08       Impact factor: 3.891

7.  A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum.

Authors:  William G Valiant; Joseph J Mattapallil
Journal:  J Vis Exp       Date:  2018-04-10       Impact factor: 1.355

Review 8.  Vaccination strategies against Zika virus.

Authors:  Estefania Fernandez; Michael S Diamond
Journal:  Curr Opin Virol       Date:  2017-04-19       Impact factor: 7.090

Review 9.  Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.

Authors:  Leah C Katzelnick; Sandra Bos; Eva Harris
Journal:  Curr Opin Virol       Date:  2020-09-24       Impact factor: 7.090

10.  Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection.

Authors:  Gary Wong; Shihua He; Vinayakumar Siragam; Yuhai Bi; Majambu Mbikay; Michel Chretien; Xiangguo Qiu
Journal:  Virol Sin       Date:  2017-12       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.